Vanguard Group
ORKA

Vanguard Group’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$20.4M Buy
1,817,307
+179,874
+11% +$2.02M ﹤0.01% 2550
2025
Q1
$16.8M Buy
1,637,433
+26,782
+2% +$275K ﹤0.01% 2586
2024
Q4
$31.2M Buy
1,610,651
+1,572,853
+4,161% +$30.5M ﹤0.01% 2369
2024
Q3
$926K Sell
37,798
-415,800
-92% -$10.2M ﹤0.01% 3799
2024
Q2
$1.74M Hold
453,598
﹤0.01% 3603
2024
Q1
$798K Hold
453,598
﹤0.01% 3884
2023
Q4
$771K Buy
453,598
+3,063
+0.7% +$5.21K ﹤0.01% 3906
2023
Q3
$906K Sell
450,535
-11,078
-2% -$22.3K ﹤0.01% 3875
2023
Q2
$937K Sell
461,613
-5,592
-1% -$11.4K ﹤0.01% 3923
2023
Q1
$930K Buy
467,205
+7,800
+2% +$15.5K ﹤0.01% 3944
2022
Q4
$1.09M Buy
459,405
+235
+0.1% +$557 ﹤0.01% 3882
2022
Q3
$946K Sell
459,170
-1,048
-0.2% -$2.16K ﹤0.01% 4022
2022
Q2
$1.15M Buy
460,218
+656
+0.1% +$1.63K ﹤0.01% 4041
2022
Q1
$1.06M Buy
459,562
+53,279
+13% +$123K ﹤0.01% 4188
2021
Q4
$874K Sell
406,283
-10,975
-3% -$23.6K ﹤0.01% 4299
2021
Q3
$1.24M Buy
417,258
+18,751
+5% +$55.5K ﹤0.01% 4201
2021
Q2
$1.39M Buy
398,507
+261,009
+190% +$911K ﹤0.01% 4075
2021
Q1
$502K Buy
137,498
+49,879
+57% +$182K ﹤0.01% 4138
2020
Q4
$351K Buy
87,619
+73,647
+527% +$295K ﹤0.01% 4018
2020
Q3
$62K Buy
+13,972
New +$62K ﹤0.01% 4054
2019
Q2
Sell
-50,481
Closed -$19K 4188
2019
Q1
$19K Hold
50,481
﹤0.01% 4100
2018
Q4
$17K Sell
50,481
-2,000
-4% -$674 ﹤0.01% 4129
2018
Q3
$29K Buy
52,481
+12,301
+31% +$6.8K ﹤0.01% 4147
2018
Q2
$22K Buy
40,180
+4,000
+11% +$2.19K ﹤0.01% 4121
2018
Q1
$18K Sell
36,180
-64,356
-64% -$32K ﹤0.01% 4092
2017
Q4
$138K Sell
100,536
-10,295
-9% -$14.1K ﹤0.01% 3977
2017
Q3
$122K Buy
110,831
+38,495
+53% +$42.4K ﹤0.01% 3975
2017
Q2
$177K Sell
72,336
-49,321
-41% -$121K ﹤0.01% 3922
2017
Q1
$304K Hold
121,657
﹤0.01% 3835
2016
Q4
$347K Hold
121,657
﹤0.01% 3802
2016
Q3
$351K Hold
121,657
﹤0.01% 3819
2016
Q2
$353K Hold
121,657
﹤0.01% 3850
2016
Q1
$417K Buy
121,657
+2,656
+2% +$9.1K ﹤0.01% 3827
2015
Q4
$553K Buy
119,001
+31,802
+36% +$148K ﹤0.01% 3805
2015
Q3
$434K Sell
87,199
-451,284
-84% -$2.25M ﹤0.01% 3892
2015
Q2
$619K Buy
538,483
+86,566
+19% +$99.5K ﹤0.01% 3804
2015
Q1
$362K Buy
451,917
+30,965
+7% +$24.8K ﹤0.01% 3899
2014
Q4
$401K Buy
420,952
+16,700
+4% +$15.9K ﹤0.01% 3790
2014
Q3
$505K Buy
404,252
+4,106
+1% +$5.13K ﹤0.01% 3706
2014
Q2
$584K Buy
400,146
+12,400
+3% +$18.1K ﹤0.01% 3637
2014
Q1
$721K Buy
387,746
+213,767
+123% +$397K ﹤0.01% 3555
2013
Q4
$292K Buy
173,979
+12,399
+8% +$20.8K ﹤0.01% 3710
2013
Q3
$257K Buy
161,580
+151,257
+1,465% +$241K ﹤0.01% 3662
2013
Q2
$13K Buy
+10,323
New +$13K ﹤0.01% 3792